· 4/2/2001
United States of America, Exrel., Insoon Lee v. Smithkline Beecham, Inc. Smithkline Beecham Clinical Laboratories Does 1-100
Citations
- 245 F.3d 1048
- 2001 Daily Journal DAR 3303
- 2001 Cal. Daily Op. Serv. 2639
- 49 Fed. R. Serv. 3d 12
- 2001 U.S. App. LEXIS 5401
- 2001 WL 310945
How courts have described this case
Verbatim parenthetical descriptions written by other courts when citing this decision. Ranked by citation-network relevance.
- holding that FCA complaints must comply with Rule 9(b) requirements mandating that allegations of fraud be pleaded with particularity
- concluding that an FCA claim lacked the requisite particularity under Rule 9(b) where, inter alia, plaintiff failed to identify the employees involved in the fraud
- holding that Plaintiff failed to plead fraud with sufficient particularity but stating that party may be entitled to lenient application of Rule 9(b) where information is in possession of corporate defendant
- holding that “[i]n an appropriate case, knowingly billing for worthless services” may be actionable
- holding that Rule 9 9(b) was not satisfied when plaintiffs did not “identify the [defendant’s] employees who 10 performed the tests, or provide any dates, times, or places the tests were conducted
- holding that Rule 9 9(b) was not satisfied when plaintiffs did not “identify the [defendant’s] employees who 10 performed the tests, or provide any dates, times, or places the tests were conducted
Source: CourtListener parenthetical corpus (CC0).
Judges: Pregerson, Fletcher, Gould
Read full opinion on CourtListenerSourced from CourtListener / Free Law Project (CC0).
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.